NR 566 FINAL EXAM V2

Study Guides Aug 17, 2025
Loading...

Loading document viewer...

Page 0 of 0

Document Text

NR 566 FINAL EXAM V2

  • Benztropine (Cogentin): minimizes resting tremor and drooling but not as efficacious as
  • other meds in treating rigidity, bradykinesia and gait problems

  • Rivastigimine (Exelon) transdermal patch: used for dementia associated with parkinsons
  • disease

  • Alzheimers disease: progressive memory loss and decreased brain function from protein
  • deposits in the brain impairing function of neurons causing them to lose connection with other brain cells and die

  • major pathologic findings: cerebral atrophy, degeneration of cholinergic neu- rons, neuritic
  • plaques and neurofibrillary tangles

5. hippocampus: memory

  • cerebral cortex: central to speech, perception, reasoning and other higher functions
  • B-Amyloid Neuritic plaques: spherical bodies of neuritic plaques made up of beta
  • amyloid. B amyloid found in high levels in AD patients and can occur 10-20 years before first symptoms appear

  • Memantine: used to treat severe dementia/AD and reduces actions of chemi- cals in the
  • brain contributing to AD. use in caution w pts hx of cardiovascular dz, hepatic/renal impairment or ophthalmic dz

9. Donepezil (Aricept): tx moderate to severe AD.

10. Cholinesterase inhibitors: donepezil, rivastigimine and galantamine

11. NMDA antagonist: memantine

12. Bipolar dz treatment (other drugs): anticonvulsants, clonazepam, lorazepam,

oxcarbazepine, antidepressants, mood stabilizers and antipsychotics

13. Mood stabilizers: lithium and divalproex sodium

  • Divalproex Sodium (Valproate): controls sx in acute manic episodes and can help prevent
  • relapse into mania. Teratogen and can cause thrombocytopenia, pan- creatitis and liver failure

  • Carbamezepine (Tegretol, Equetro): approved for tx and prevention of manic episodes.
  • Neuro side effects-- visual disturbances, ataxia, vertigo, unsteadiness, headache

  • Lithium: drug of choice for controlling manic episodes and for long term ppx against
  • recurrence of mania or depression. monitoring is mandatory

  • Lithium can accumulate to toxic levels in what sodium level...: LOW SODI- UM. edu
  • patients to maintain normal sodium intake

  • Diuretics and lithium: these promote sodium loss and can increase r/f lithium toxicity
  • NSAIDs and lithium: increase lithium levels by 60% 1 / 2
  • NSAIDs to prescribe when on lithium if necessary: aspirin or sulindac bc they do not
  • increase levels

21. Lithium drug interactions: diruetics, NSAIDs and anticholinergics

  • Anticholinergics and lithium: cause urinary hesitancy + lithium induced polyuria which
  • can cause discomfort. AVOID antihistamines, phenothiazine, antipsy- chotics and TCAs

  • Lithium level monitoring: measure levels every 2-3 days during initial therapy and every
  • 3-6 months during maintenance. Serum levels checked 5 days after any dosage change and 6 months thereafter

  • LIthium can be toxic to what other organs: renal and thyroid. Check renal/thy- roid function
  • every 6 months

  • SSRIs for MDD: fluoxetine, citalopram, escitalopram, fluvoxamine, paroxetine and
  • sertraline

  • Adverse effects of Venlafaxine: nausea, HA, anorexia, nervousness, sweating, somnolence,
  • insomnia, dose related sustained diastolic HTN, mydriasis, sexual dysfunction.

  • Venlafaxine drug interaction: combo with MAOI is contraindicated. (this drug is an SNRI)
  • MAOI adverse effects: hypertensive crisis triggered by foods containing tyra- mine.

29. s/s hypertensive crisis: HA, tachycardia, palpitations, N/V, sweating

  • Foods containing tyramine: strong aged cheese, cured meats with salt or nitrate, dry
  • summer sausages, pepperoni, sausage, avocado, figs, yeast extract, chianti wine, shrimp paste and soy sauce

  • Pt appropriate for MAOI: patients who do NOT respond well to first line drugs (SSRIs)
  • Baseline data/education for SSRI: serum sodium. Edu not to abruptly stop med. report
  • suicide thoughts

33. Baseline data/pt edu for TCAs: ECG in pts with known dysrhythmia or

>40years. Edu ortho hypotension and anticholinergic effects

34. Tricyclic Antidepressants drugs: amitriptyline, nortriptyline, doxepin etc.

  • MAOI baseline data/pt edu: blood pressure. Edu pts on tyramine containing foods and s/s
  • hypertensive crisis

36. Preferred tx for panic disorder: SSRIs + CBT. Can use benzos, SNRIs too.

  • Social anxiety disorder tx: psychotherapy + paroxetine or sertraline (SSRIs). PRN use
  • benzo.

  • Raloxifene (Evista) and bisphosphonates (alendronate, calcitonin): alterna- tives for
  • hormone replacement therapy

  • Selective Estrogen Receptor Modulators (SERMs): Tamoxifen, toremifene, raloxifene --
  • provide estrogen benefits while avoiding its drawbacks

  • / 2

Download Document

Buy This Document

$30.00 One-time purchase
Buy Now
  • Full access to this document
  • Download anytime
  • No expiration

Document Information

Category: Study Guides
Added: Aug 17, 2025
Description:

NR 566 FINAL EXAM V2 1. Benztropine (Cogentin): minimizes resting tremor and drooling but not as efficacious as other meds in treating rigidity, bradykinesia and gait problems 2. Rivastigimine (Exe...

Get this document $30.00